Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,307 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06673121Recruiting
Chinese Medicine Study for Lung Nodules
This study looks at whether traditional Chinese medicine can help people with lung nodules that are being watched by a doctor. It may help guide treatment options for those not needing immediate surgery.
Zhengzhou, HenanAges Any age - NCT06546943Recruiting
Glucose monitoring in youth with cystic fibrosis
This study uses a continuous glucose monitor (a small sensor on the arm) to track blood sugar levels in young people with cystic fibrosis during a lung infection flare-up (called a pulmonary exacerbation). It aims to see if glucose changes can help guide treatment.
Aurora, ColoradoAges 6–25 - NCT06453421Recruiting
Breathing and exercise rehab for long-term breathing machine patients
This study tests a special breathing and exercise program for people who have been on a breathing machine for a long time through a tracheostomy. The program is designed to help them get stronger and breathe better.
FlorenceAges 18 years+ - NCT06548802RecruitingPhase 1/Phase 2
Baricitinib for lung injury after brain bleed
This trial tests a pill called baricitinib to see if it helps people recover from lung injury after a brain bleed. It is for patients who need a breathing machine due to ARDS that started within a week of the bleed.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06396767Recruiting
Breathing test before heart surgery to predict lung problems
This study uses a simple breathing test before scheduled heart surgery to see if it can help predict breathing or lung complications after the operation. The results may help doctors identify patients who need extra support during recovery.
London, OntarioAges 19–99 - NCT06198309Recruiting
Predicting worsening COPD in severe patients
This study builds a tool to predict which COPD patients are likely to have worsening symptoms. It may help your doctor better manage your care if you have severe COPD.
Beijing, Beijing MunicipalityAges 40–85 - NCT07357623RecruitingPhase 2
Surufatinib with or without chemo for lung neuroendocrine tumors
This trial tests whether adding chemotherapy to the drug surufatinib works better than surufatinib alone for people with a rare type of lung cancer called pulmonary neuroendocrine tumor. If you have this diagnosis and haven't had prior systemic treatment, you may be eligible.
Hefei, AnhuiAges 18–75 - NCT07309393Recruiting
Comparing two muscle relaxant reversal drugs after lung surgery
This trial tests two different medicines used to reverse muscle relaxation after lung surgery. It looks at which one helps you breathe better in the first hours after your procedure.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07724197Recruiting
Using a new imaging test to find blood clots in the lungs
This study tests a new, non-invasive imaging method called pulsatile electrical impedance tomography (EIT) to help diagnose and monitor acute pulmonary embolism (blood clots in the lungs). It may provide a faster or safer way to detect clots compared to standard CT scans, especially for patients who cannot have contrast dye.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06418087RecruitingPhase 2
Durvalumab plus chemotherapy for advanced LCNEC
This trial tests a combination of a new immunotherapy drug (durvalumab) with standard chemotherapy for people with a rare, advanced form of lung cancer called LCNEC. It aims to see if this combination can shrink tumors or slow the cancer’s growth better than chemotherapy alone.
Bologna, BOAges 18 years+ - NCT07593027RecruitingPhase 1/Phase 2
Study of IMC-003 for pulmonary arterial hypertension
This trial tests a new drug called IMC-003 for people with pulmonary arterial hypertension (PAH). It aims to see if the drug can help improve symptoms and exercise ability when added to your current PAH medications.
Beijing, Beijing MunicipalityAges 18–75 - NCT07389083Recruiting
Nose breathing tube for deep sedation lung exam
This study tests a breathing tube put through the nose to deliver oxygen during a lung exam (bronchoscopy) while you are deeply sedated. It aims to find a safer and more comfortable way to keep your oxygen levels up during the procedure.
Hangzhou, ZhejiangAges 18 years+ - NCT07125352Recruiting
NLR blood test for COPD flare-ups
This study looks at whether the neutrophil-to-lymphocyte ratio (NLR) in your blood can help doctors understand how serious a COPD flare-up is. You may join if you are 18 or older and admitted to the hospital with a COPD exacerbation.
Cairo, AbbasyeaAges 18 years+ - NCT06440408RecruitingPhase 1
Measuring blood flow in infant lung veins
This study uses special MRI scans to measure blood flow in the veins of the lungs in babies, aiming to help doctors better understand and treat conditions like chronic lung disease or abnormal vein connections.
Philadelphia, PennsylvaniaAges Up to 18 years - NCT07318597RecruitingPhase 2
A study of an experimental drug for pulmonary arterial hypertension
This trial tests a new medication called REGN13335 for people with pulmonary arterial hypertension (PAH). It aims to see if the drug can improve symptoms and function compared to standard care alone.
Aurora, ColoradoAges 18 years+ - NCT06911632Recruiting
AI-assisted check for pulmonary hypertension in interstitial lung disease
This study uses an AI tool to help doctors decide if you should be tested for pulmonary hypertension (high blood pressure in the lungs), which can be a complication of interstitial lung disease. If the tool suggests you might have it, you may get an echocardiogram (an ultrasound of the heart) and a right heart catheterization (a test to measure pressure in the heart) to find out for sure.
Birmingham, AlabamaAges 18 years+ - NCT07725939RecruitingPhase 2
Study of Galvokimig for moderate-to-severe COPD with chronic bronchitis
This study tests an experimental drug called Galvokimig (taken as a pill) to see if it can reduce COPD flare-ups and improve lung function in people with moderate to severe COPD and chronic bronchitis. It is for those who have had recent flare-ups and are already using maintenance inhalers.
Boerne, TexasAges 40–80 - NCT06481852RecruitingPhase 1
Gut bacteria transplant for pulmonary arterial hypertension
This trial tests whether a special combination of antibiotics, fecal transplant (gut bacteria from healthy donors), and a fiber supplement can help people with pulmonary arterial hypertension (PAH). It aims to see if improving gut health can improve PAH symptoms and overall well-being.
Minneapolis, MinnesotaAges 18–75 - NCT06770023RecruitingPhase 1
Bridge to lung transplant with ECMO for right heart failure
This study tests a special heart-lung support machine (ECMO) for people waiting for a lung transplant whose heart is failing due to high blood pressure in the lungs. The machine helps rest the heart and lungs until transplant surgery.
Jacksonville, FloridaAges 18–80 - NCT06169397Enrolling by invitationPhase 2
Extension study of XTMAB-16 for pulmonary sarcoidosis
This study is an extension of a previous trial for the drug XTMAB-16 in people with pulmonary sarcoidosis. It allows patients who completed the earlier study to continue receiving the treatment and be monitored for safety and effectiveness.
Denver, ColoradoAges 18–80 - NCT07036523RecruitingPhase 2
Study of BI 765423 for people with Idiopathic Pulmonary Fibrosis (IPF)
This trial tests a new medicine, BI 765423, to see if it can improve lung function in people with IPF, a lung scarring disease. You can join whether or not you are already taking standard treatments like nintedanib or pirfenidone.
Birmingham, AlabamaAges 40 years+ - NCT07177339RecruitingPhase 3
Testing depemokimab for COPD with type 2 inflammation
This study tests an early treatment called depemokimab for people with moderate to severe COPD who have a type of inflammation linked to high eosinophils. It aims to reduce flare-ups and improve breathing.
Newport Beach, CaliforniaAges 40–75 - NCT04905693Enrolling by invitationPhase 3
Extension inhaled treprostinil study for fibrotic lung disease
This is an add-on (extension) study testing whether continuing inhaled treprostinil can help people with fibrotic lung disease who took part in earlier related studies. It mainly continues treatment and follow-up for eligible participants.
Birmingham, AlabamaAges 40 years+ - NCT07473700RecruitingPhase 2
Study of TX000045 for lung scarring and high blood pressure in the lungs
This trial tests a new medicine called TX000045 for people who have both lung scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). It aims to see if the drug can help improve breathing and daily function.
Phoenix, ArizonaAges 18–80
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,307 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.